Jbtor 10mg Tablet contains Torasemide, a potent loop diuretic indicated for the management of edema associated with congestive heart failure, renal impairment, and hepatic cirrhosis. Each tablet delivers 10mg of Torasemide, which acts by inhibiting the sodium-potassium-chloride co-transporter in the thick ascending limb of the loop of Henle, promoting increased excretion of sodium, chloride, and water. This mechanism effectively reduces fluid overload and decreases blood pressure, making it beneficial in treating hypertension resistant to other diuretics. Jbtor 10mg is typically administered once daily, with dosage adjustments based on clinical response and patient condition. The drug’s pharmacokinetic profile includes good oral bioavailability and a relatively long half-life, allowing sustained diuretic action. Patients should be monitored for electrolyte imbalances, particularly hypokalemia, as well as renal function during therapy. Caution is advised in individuals with severe renal impairment or hypersensitivity to sulfonamides. Common adverse effects may include dizziness, dehydration, and gastrointestinal disturbances. Jbtor 10mg Tablet should be used under medical supervision, with periodic assessment to optimize therapeutic outcomes and minimize potential risks.